Brown Spencer D. has filed 4 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 300000 shares of PDS Biotechnology Corp ($PDSB) on January 12, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 12, 2026 | PDS Biotechnology Corp | $PDSB | Brown Spencer D. | Senior VP, General Counsel | A | Employee Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 48,980,307 | 9999.99% | 0.61% |
| Feb. 28, 2024 | PDS Biotechnology Corp | $PDSB | Brown Spencer D. | Senior VP, General Counsel | A | Employee Stock Option (Right to Buy) | 56000 | $0.00 | 56,000.0000 | 0 | 9999.99% | 0.00% |
| June 12, 2025 | PDS Biotechnology Corp | $PDSB | Brown Spencer D. | Senior VP, General Counsel | A | Employee Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 45,395,851 | 9999.99% | 0.33% |
| Jan. 5, 2023 | PDS Biotechnology Corp | $PDSB | Brown Spencer D. | Senior VP, General Counsel | A | Employee Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 0 | 9999.99% | 0.00% |